TriangleAshwagandha + Liposomal Doxorubicin (NCT05610735)
Ashwagandha + Liposomal Doxorubicin trial for Recurrent Ovarian Cancer (NCT05610735). This is a short film with English narration. The transcript is on this page, and the written brief is separate.
What the film says
Read the transcript
This trial is for adults with recurrent ovarian cancer for whom liposomal doxorubicin is a treatment option.
The idea: add ashwagandha, a plant extract containing withaferin A, taken as tablets by mouth, to the chemotherapy liposomal doxorubicin, given by vein every four weeks. The first part tests three ashwagandha doses.
This phase 1 and 2 study plans 72 patients and looks at feasibility, the maximum tolerated dose and progression free survival. At the University of Louisville's Brown Cancer Center, Whitney Goldsberry leads it.
Public record; not medical advice.
Already in a trial?
It turns into a project to manage: visits, scans, labs, side effects and paperwork. Triangle keeps it organized in one place for you or for whoever's helping.
Organize my trial7-day free trial, then $9 a month. Cancel anytime.
How these trials work: what Phase 1 actually is · common questions Not clinical evidence.